BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1013 related articles for article (PubMed ID: 32972442)

  • 1. A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction.
    Sweetman E; Kleffmann T; Edgar C; de Lange M; Vallings R; Tate W
    J Transl Med; 2020 Sep; 18(1):365. PubMed ID: 32972442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in DNA methylation profiles of myalgic encephalomyelitis/chronic fatigue syndrome patients reflect systemic dysfunctions.
    Helliwell AM; Sweetman EC; Stockwell PA; Edgar CD; Chatterjee A; Tate WP
    Clin Epigenetics; 2020 Nov; 12(1):167. PubMed ID: 33148325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioenergetic and Proteomic Profiling of Immune Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients: An Exploratory Study.
    Fernandez-Guerra P; Gonzalez-Ebsen AC; Boonen SE; Courraud J; Gregersen N; Mehlsen J; Palmfeldt J; Olsen RKJ; Brinth LS
    Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    de Vega WC; Herrera S; Vernon SD; McGowan PO
    BMC Med Genomics; 2017 Feb; 10(1):11. PubMed ID: 28231836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.
    Morris G; Maes M
    Metab Brain Dis; 2014 Mar; 29(1):19-36. PubMed ID: 24557875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-associated DNA methylation patterns.
    Trivedi MS; Oltra E; Sarria L; Rose N; Beljanski V; Fletcher MA; Klimas NG; Nathanson L
    PLoS One; 2018; 13(7):e0201066. PubMed ID: 30036399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased nuclear factor-κB and loss of p53 are key mechanisms in Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS).
    Morris G; Maes M
    Med Hypotheses; 2012 Nov; 79(5):607-13. PubMed ID: 22951418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unravelling myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Gender-specific changes in the microRNA expression profiling in ME/CFS.
    Cheema AK; Sarria L; Bekheit M; Collado F; Almenar-Pérez E; Martín-Martínez E; Alegre J; Castro-Marrero J; Fletcher MA; Klimas NG; Oltra E; Nathanson L
    J Cell Mol Med; 2020 May; 24(10):5865-5877. PubMed ID: 32291908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study.
    Giloteaux L; O'Neal A; Castro-Marrero J; Levine SM; Hanson MR
    J Transl Med; 2020 Oct; 18(1):387. PubMed ID: 33046133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The status of and future research into Myalgic Encephalomyelitis and Chronic Fatigue Syndrome: the need of accurate diagnosis, objective assessment, and acknowledging biological and clinical subgroups.
    Twisk FN
    Front Physiol; 2014; 5():109. PubMed ID: 24734022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Isolated Complex V Inefficiency and Dysregulated Mitochondrial Function in Immortalized Lymphocytes from ME/CFS Patients.
    Missailidis D; Annesley SJ; Allan CY; Sanislav O; Lidbury BA; Lewis DP; Fisher PR
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32041178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
    Bested AC; Marshall LM
    Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
    Shukla SK; Cook D; Meyer J; Vernon SD; Le T; Clevidence D; Robertson CE; Schrodi SJ; Yale S; Frank DN
    PLoS One; 2015; 10(12):e0145453. PubMed ID: 26683192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing a Blood Cell-Based Diagnostic Test for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Using Peripheral Blood Mononuclear Cells.
    Xu J; Lodge T; Kingdon C; Strong JWL; Maclennan J; Lacerda E; Kujawski S; Zalewski P; Huang WE; Morten KJ
    Adv Sci (Weinh); 2023 Oct; 10(30):e2302146. PubMed ID: 37653608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls.
    Giloteaux L; Li J; Hornig M; Lipkin WI; Ruppert D; Hanson MR
    J Transl Med; 2023 May; 21(1):322. PubMed ID: 37179299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-specific plasma lipid profiles of ME/CFS patients and their association with pain, fatigue, and cognitive symptoms.
    Nkiliza A; Parks M; Cseresznye A; Oberlin S; Evans JE; Darcey T; Aenlle K; Niedospial D; Mullan M; Crawford F; Klimas N; Abdullah L
    J Transl Med; 2021 Aug; 19(1):370. PubMed ID: 34454515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome.
    Yang CA; Bauer S; Ho YC; Sotzny F; Chang JG; Scheibenbogen C
    J Transl Med; 2018 Aug; 16(1):231. PubMed ID: 30119681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Post-Exertional Malaise on Markers of Arterial Stiffness in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Bond J; Nielsen T; Hodges L
    Int J Environ Res Public Health; 2021 Feb; 18(5):. PubMed ID: 33671082
    [No Abstract]   [Full Text] [Related]  

  • 19. [Myalgic encephalomyelitis or chronic fatigue syndrome].
    Brinth L; Nielsen H; Varming K; Boonen SE; Ebsen ACG; Fernández-Guerra P; Schou AS; Mehlsen J; Gregersen N; Brandslund I; Olsen RKJ
    Ugeskr Laeger; 2019 Jun; 181(24):. PubMed ID: 31267953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): increased interleukin-1, tumor necrosis factor-α, PMN-elastase, lysozyme and neopterin.
    Maes M; Twisk FN; Kubera M; Ringel K
    J Affect Disord; 2012 Feb; 136(3):933-9. PubMed ID: 21975140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.